3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Bevacizumab
75
Fluorouracil
55
Cetuximab
47
Oxaliplatin
43
Leucovorin
43
pembrolizumab
35
Irinotecan
33
Folfox protocol
24
Capecitabine
24
HMPL-013
22
Specimen Handling
18
trifluridine tipiracil drug combination
16
Nivolumab
15
Blood Specimen Collection
15
Panitumumab
14
regorafenib
13
Magnetic Resonance Spectroscopy
13
Trifluridine
12
Gemcitabine
12
Biopsy
12
Standard of Care
11
Cisplatin
11
sintilimab
10
Interviews as Topic
10
IFL protocol
10
Drug Therapy
10
Carboplatin
9
tislelizumab
8
Trastuzumab
8
Cyclophosphamide
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Colorectal Neoplasms
×
sodium phosphate
×
Clear all
NCT05148494
2024-08-27
TESEO
Nova Scotia Health Authority
Phase 4
Recruiting
66 enrolled